F Lecuru
Overview
Explore the profile of F Lecuru including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
624
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buchalet C, Loap P, Losa S, Laas E, Gaillard T, Lecuru F, et al.
Eur J Surg Oncol
. 2024 Apr;
50(6):108342.
PMID: 38636247
Objective: The treatment of early-stage cervical cancer (CC) is primarily based on surgery. Adjuvant (chemo)radiotherapy can be necessary in presence of risk factors for relapse (tumor size, deep stromal invasion,...
2.
Kissel M, Balaya V, Guani B, Magaud L, Mathevet P, Lecuru F
Gynecol Oncol
. 2023 Feb;
170:309-316.
PMID: 36758421
Introduction: The goal of this study was to compare the outcomes of preoperative brachytherapy followed by radical surgery versus radical surgery alone in cervical cancer with tumor between 2 and...
3.
Messaoud L, Amiot H, Lecuru F, Cottu P, Cassou-Mounat T
Rev Esp Med Nucl Imagen Mol (Engl Ed)
. 2023 Jan;
42(1):38-39.
PMID: 36639178
No abstract available.
4.
Akladios C, Darai E, Golfier F, Lecuru F, Collinet P, Uzan C, et al.
Gynecol Obstet Fertil Senol
. 2021 Nov;
50(1):26-32.
PMID: 34774853
Objective: In France, we are lacking an identified pathway for training in gynaecological cancer surgery. The four competent French learned societies, the SFOG, the CNGOF, the SFCO and the SCGP,...
5.
Derquin F, Floquet A, Hardy-Bessard A, Edeline J, Lotz J, Alexandre J, et al.
Gynecol Oncol
. 2020 Jul;
158(3):666-672.
PMID: 32624235
Background: Malignant ovarian germ cell tumors are rare tumors, affecting young women with a generally favorable prognosis. The French reference network for Rare Malignant Gynecological Tumors (TMRG) aims to improve...
6.
Balaya V, Guani B, Benoit L, Magaud L, Bonsang-Kitzis H, Ngo C, et al.
Gynecol Oncol
. 2020 Jun;
158(3):576-583.
PMID: 32595022
Objectives: We aimed to assess the diagnostic value of frozen-section pathologic examination (FSE) of sentinel lymph nodes (SLN) in patients with early-stage cervical cancer. Methods: Two French prospective multicentric database...
7.
Simon V, Ngo C, Pujade-Lauraine E, Ferron G, Pomel C, Leblanc E, et al.
Ann Surg Oncol
. 2020 Apr;
27(10):3882-3890.
PMID: 32246309
Background: Low-grade serous ovarian carcinoma (LGSOC) is a rare disease that accounts for 5% of all ovarian cancers and requires surgical complete debulking. To date, the prognostic value of pelvic...
8.
Lenck C, Chopin N, Gouy S, Bonsang-Kitzis H, Martinez-Gomez C, Radosevic-Robin N, et al.
Gynecol Oncol
. 2020 Mar;
157(1):78-84.
PMID: 32131977
Objective: The French national rare gynecological tumor network has been established to improve the quality of care through offering expertise in double reading histological diagnosis, reviewing cases and guiding management...
9.
Kissel M, Rambeau A, Achkar S, Lecuru F, Mathevet P
Cancer Treat Rev
. 2020 Feb;
84:101976.
PMID: 32006796
With population ageing, cancer treatments in elder patients is becoming a true public health care issue. There is an authentic dilemma between patient's frailty, residual life expectancy and the toll...
10.
Balaya V, Bresset A, Guani B, Magaud L, Montero Macias R, Delomenie M, et al.
Gynecol Oncol
. 2019 Dec;
156(1):93-99.
PMID: 31839343
Background: The objective of this study was to determine clinical, tumoral and surgical factors associated with successful bilateral sentinel lymph node mapping (SBM) in early-stage cervical cancer. Methods: We performed...